Login to Your Account

Novartis Remaining Busy, Buying NeuTec For £305M

By Nuala Moran

Wednesday, June 14, 2006
LONDON - Another UK antibody company was swept up, as Novartis AG sealed a recommended all-cash offer worth £305.1 million (US$569 million) for NeuTec Pharma plc, paying more than twice the Manchester-based company's market capitalization. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription